IAAG
NVS icon

Innovative Asset Advisors Group’s Novartis NVS Stock Holding History

Innovative Asset Advisors Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-573
Closed -$87.5K – 775
2026
Q1 		$87.5K Buy
+573
New +$87.8K 0.05% 233

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $88.9B AUM 38.03% 1-Year Est. Return

Innovative Asset Advisors Group's NVS Position: Q2 2026 in Review

Innovative Asset Advisors Group sold out of Novartis (NVS) in Q2 2026, closing a stake of 573 shares — an estimated $87.5K sold.

Innovative Asset Advisors Group first reported a position in NVS in Q1 2026 and held it in 1 quarter. The position peaked at $87.5K in Q1 2026. 1,546 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Innovative Asset Advisors Group reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
  • Innovative Asset Advisors Group sold 573 Novartis shares in Q2 2026, an estimated $87.5K.
  • Innovative Asset Advisors Group first reported a position in Novartis in Q1 2026 and held it in 1 quarter.
  • Innovative Asset Advisors Group's Novartis position peaked at $87.5K in Q1 2026.
  • 1,546 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Innovative Asset Advisors Group's 13F filing for Q2 2026, filed 5 Aug 2026.